Janelle Lennie, Ph.D.

Research Scientist II

Janelle joined Metrum Research Group in June of 2012. She was accepted into the Biomedical Engineering Ph.D. program at the University of Connecticut in 2014, with support and academic advisement through Metrum Institute, and worked part-time as a Research Associate at Metrum Research Group while pursuing her Ph.D. Janelle successfully defended her dissertation titled “Assessment of Early Decision-Making Methods in Duchenne Muscular Dystrophy Clinical Trials: A Bayesian Modeling & Simulation Approach to Orphan Drug Development” in November of 2020, then began a Research Scientist I position at Metrum.

Recent publications by this scientist

Extrapolation of Efficacy of a Dextroamphetamine Transdermal System from Pediatric to Adult Populations Using Pharmacokinetic Modeling.

October 7, 2022

Mariacristina Castelli, Katsumi Suzuki, Brittney Starling, Kanan Balakrishnan, Suzanne Meeves, Marina Komaroff, Janelle Lennie, John T. Mondick, Stephen V. Faraone.
Presented at the American Society of Clinical Psychopharmacology Annual Meeting, May 31–June 3, 2022, in Scottsdale, AZ. Poster #W2

Download PDF

Bayesian modeling and simulation to inform rare disease drug development early decision-making: Application to Duchenne muscular dystrophy

April 28, 2022

Janelle L. Lennie, John T. Mondick, Marc R. Gastonguay. PLoS One. 2022 Apr 28;17(4):e0247286. doi: 10.1371/journal.pone.0247286.

View More

Latent process model of the 6-minute walk test in Duchenne muscular dystrophy

January 30, 2020

Lennie, J.L., Mondick, J.T. & Gastonguay, M.R. Latent process model of the 6-minute walk test in Duchenne muscular dystrophy. J Pharmacokinet Pharmacodyn (2020).

View More